Ann: Corporate Presentation, page-24

I expect a pretty decent news flow before the end of the year and in January next year.

As you talked about the commercial launch of the cardiology arm is happening this quarter. (1 month left) and the commercial launch of the Pathology arm is next quarter. Both providing possible 5 year contracts adding significantly to the TCR and the AAR.

At the moment the radiology business is in a pilot stage in Australia and we may see some more news on that soon also.

For anyone looking at the SP movements I thoroughly believe this is being controlled and quite deliberately to churn and accumulate. Don't get caught out by this imo. A lot of quality stocks have been pushed down during the soft overall conditions and accumulated or at least tried too. The volumes on IME have been miniscule to the volumes bought at much higher prices.

Plenty of news flow to take this much higher imo.